16 December 2024
Duke Capital
Limited
("Duke
Capital", "Duke" or the "Company")
Interim Results for the six
months ended 30 September 2024
Duke Capital Limited (AIM: DUKE), a
leading provider of hybrid capital solutions for SME business
owners in Europe and North America, is pleased to announce its
interim results for the six-months ended 30 September 2024
("Interim 2025").
Financial Highlights
·
Recurring cash revenue* totalled £12.7 million, an
increase of 4% on Interim 2024 (£12.2 million)
·
Total cash revenue of £13.5 million, down 4% from
the prior period (Interim 2024: £14.1 million)
·
Free cash flow** of £5.9 million, down 26% from
Interim 2024 (£7.9 million) - fewer investment exits delivered in
the current period compared to Interim 2024
·
Cash dividends of 1.40 pence per share paid to
shareholders (Interim 2024: 1.40 pence per share)
Operational Highlights
·
Deployed over £15 million of capital into existing
Capital Partners
·
Completed a £23.5 million fundraise post period
end to support portfolio M&A and progress Duke's third party,
non-dilutive funding strategy to accelerate scale
·
Positive outlook with a number of buy and build
opportunities in the portfolio's pipeline and a diversified
portfolio positioned for continued resilience
*Recurring cash revenue excludes
exit premiums and cash gains from the sale of equity
investments
** Free cashflow is defined as net
cash inflows from operations plus cash gains from the sale of
equity investments less investment costs less interest paid on
borrowings
Nigel Birrell, Chairman of Duke
Capital, said:
"During the first six months of FY
2025, we have continued to prove our ability to deliver. We
continue to increase recurring cash revenue, driven by the team's
successful execution on several growth opportunities. This is
testament to the quality of the portfolio we have established and
the significant potential it holds for continued capital
appreciation. With a strong, well-funded balance sheet and numerous
growth opportunities under review, we have a positive outlook for
the months ahead. The private credit and direct lending markets
continue to go from strength to strength and we have confidence
that our diversified portfolio is well positioned for continued
resilience. We look forward to updating the markets on our
progress."
For further information, please
visit www.dukecapital.com
or contact:
Duke Capital Limited
|
Neil Johnson / Charles Cannon
Brookes / Hugo Evans
|
+44 (0)
1481 231 816
|
Cavendish Capital Markets Limited
(Nominated Adviser and Joint Broker)
|
Stephen Keys / Callum Davidson /
Michael Johnson
|
+44 (0)
207 220 0500
|
|
|
|
Canaccord Genuity Limited
(Joint Broker)
|
Adam James / Harry Rees
|
+44 (0)
207 523 8000
|
SEC Newgate
(Financial Communications)
|
Elisabeth Cowell / Alice Cho /
Olivia Hart
|
+44 (0) 20
3757 6882 dukecapital@secnewgate.co.uk
|
About Duke Capital
Duke is a leading provider of hybrid
capital solutions for SME business owners in Europe and North
America, combining the best features of both equity and
debt.
Since 2017, Duke has provided unique
long-term financing which eliminates re-financing risk and
necessity for a short-term exit by providing a unique 'corporate
mortgage' while also aligning its returns to grow with the success
of the business.
Duke is focused on generating
attractive risk-adjusted returns for shareholders and has a track
record of achieving this across market cycles. Its three investment
pillars are capital preservation, attractive dividend yield, and to
provide upside upon exits. Duke is listed on the AIM market under
the ticker DUKE and is headquartered in Guernsey.
CHAIRMAN'S REPORT
Dear Shareholder,
During the six-month period, I am
pleased to report that Duke Capital has continued to build on its
consistent track record of delivery, particularly in terms of
increasing its quarterly recurring cash revenue. Notably, the
Company completed seven follow-on investments during the period to
enable our capital partners to deliver on their buy and build
strategies, deploying over £15 million of capital and resulting in
an increase in the maturity and profitability of the underlying
portfolio. It is our belief that this maturing of the portfolio,
with Duke "staying in for longer", will benefit shareholders by
positioning us to attract higher EBITDA multiples upon exit. As has
been the case for the past two and a half years, the growth we
delivered during the period was funded by non-dilutive means,
drawing down on the Company's debt line with Fairfax alongside the
reinvestment of proceeds from the high IRR exits we have
achieved.
Building on the strategic review we
undertook in the last financial year, we have been developing a
long-term funding strategy which is not reliant on raising equity
via the UK public equity markets. Alongside a unique and compelling
product, we now have an almost eight-year track record of
resilience which clearly showcases the highly attractive
fundamentals of our business model in terms of the exposure it
offers to a unique segment of the private markets and the strong
recurring cash revenue and free cash flow it supports.
This underpins the Board's belief
that the time is right to move towards a third-party capital model
and as such, we intend to raise future additional capital via new
Managed Account / Joint Venture structures. The clear benefits of
this strategy will be to eliminate cash drag, deliver accretive
fee-based revenue and reduce Duke's dependence on the UK public
equity markets, thereby minimising dilution and enabling us to
execute on strategic growth opportunities more rapidly and at
scale. With this in mind, during the period, Duke engaged a
placement agent to approach potential capital providers and, as
previously announced, has received indicative term sheets from
Tier-1 capital providers on potential new funding, with further
term sheets expected.
In the meanwhile, as we progress
towards this goal, we took the strategic decision to undertake a
targeted fundraise via the public markets post period end. This
decision was not taken lightly and reflected the near-term
investment opportunities and requirements from inside the Company's
existing portfolio specifically in relation to Duke's buy and build
platforms. The fundraising included an offer to our retail
shareholder base and delivered £23.5 million of new funding by way
of a Placing, Subscription, Retail Offer and Broker Option. The
proceeds will be used to provide additional capital to our current
partners, enabling them to deliver bolt-on M&A to build their
EBITDA and increasing our equity participation where
possible.
Outlook
With a strong, well-funded balance
sheet and numerous growth opportunities we maintain a positive
outlook for the months ahead, albeit we recognise the need for
caution in relation to the UK economy. Positively, we have
witnessed good growth in our Irish and North American partners and
have confidence that our diversified portfolio is well positioned
to continue its resilience. The private credit and direct lending
markets continue to go from strength to strength, and we have a
clear strategy to meaningfully drive future scale. I would like to
take this opportunity to thank our shareholders, team and advisers
for their continued support.
Nigel Birrell
Chairman
CONDENSED CONSOLIDATED STATEMENT OF
CASHFLOWS
|
Note
|
Period
to
|
|
Year
to
|
|
Period
to
|
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
|
£000
|
|
£000
|
|
£000
|
Cash flows
from operating activities
|
|
|
|
|
|
|
Receipts
from hybrid credit investments
|
6
|
12,775
|
|
27,267
|
|
13,720
|
Receipts of
interest from term credit investments
|
7
|
117
|
|
453
|
|
259
|
Other
operating receipts
|
|
652
|
|
195
|
|
45
|
Operating
expenses paid
|
|
(2,614)
|
|
(4,015)
|
|
(2,383)
|
Payments
for hybrid credit participation fees
|
9
|
(46)
|
|
(130)
|
|
(68)
|
Tax
paid
|
|
(607)
|
|
(673)
|
|
(498)
|
Net cash
inflow from operating activities
|
|
10,277
|
|
23,097
|
|
11,075
|
|
|
|
|
|
|
|
Cash flows
from investing activities
|
|
|
|
|
|
|
Hybrid
credit investments advanced
|
6
|
(15,322)
|
|
(42,012)
|
|
(17,102)
|
Hybrid
credit investments repaid
|
6
|
3,987
|
|
17,636
|
|
7,041
|
Term credit
investments advanced
|
7
|
-
|
|
(750)
|
|
-
|
Equity
investments purchased
|
8
|
-
|
|
(3,799)
|
|
(926)
|
Equity
investments sold
|
8
|
-
|
|
2,326
|
|
|
Equity
dividends received
|
8
|
21
|
|
48
|
|
48
|
Receipt of
deferred consideration
|
10
|
742
|
|
1,512
|
|
750
|
Investments
costs paid
|
|
(273)
|
|
(1,344)
|
|
(358)
|
Net cash
outflow from investing activities
|
|
(10,845)
|
|
(26,383)
|
|
(10,547)
|
|
|
|
|
|
|
|
Cash flows
from financing activities
|
|
|
|
|
|
|
Dividends
paid
|
17
|
(5,817)
|
|
(11,524)
|
|
(5,709)
|
Proceeds
from loans
|
12
|
17,000
|
|
15,000
|
|
5,000
|
Interest
paid
|
12
|
(4,162)
|
|
(6,222)
|
|
(2,819)
|
Other
finance costs paid
|
|
(4)
|
|
-
|
|
-
|
Net cash
inflow / (outflow) financing activities
|
|
7,017
|
|
(2,746)
|
|
(3,528)
|
|
|
|
|
|
|
|
Net change
in cash and cash equivalents
|
|
6,449
|
|
(6,032)
|
|
(3,000)
|
|
|
|
|
|
|
|
Cash and
cash equivalents at beginning of period / year
|
|
2,896
|
|
8,939
|
|
8,939
|
Effect of
foreign exchange on cash
|
|
(164)
|
|
(11)
|
|
32
|
|
|
|
|
|
|
|
Cash and
cash equivalents at the end of period / year
|
|
9,181
|
|
2,896
|
|
5,971
|
CONDENSED
CONSOLIDATED STATEMENT OF INCOME
|
|
Period
to
|
|
Year
to
|
|
Period
to
|
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
Note
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
|
£000
|
|
£000
|
|
£000
|
Income
|
|
|
|
|
|
|
Hybrid
credit investment income
|
6
|
8,512
|
|
23,014
|
|
13,514
|
Term credit
investment income
|
7
|
117
|
|
453
|
|
259
|
Equity
investment income
|
8
|
990
|
|
1,925
|
|
(3,442)
|
Other
operating income
|
|
652
|
|
195
|
|
45
|
Total
Income
|
|
10,271
|
|
25,587
|
|
10,376
|
|
|
|
|
|
|
|
Investment
costs
|
|
|
|
|
|
|
Transaction
costs
|
|
(115)
|
|
(475)
|
|
(21)
|
Due
diligence costs
|
|
36
|
|
(645)
|
|
(309)
|
Total
investment costs
|
|
(79)
|
|
(1,120)
|
|
(330)
|
|
|
|
|
|
|
|
Operating
costs
|
|
|
|
|
|
|
Administration and personnel
|
|
(2,286)
|
|
(3,072)
|
|
(2,033)
|
Legal and
professional
|
|
(258)
|
|
(533)
|
|
(274)
|
Other
operating costs
|
|
(216)
|
|
(370)
|
|
(131)
|
Expected
credit losses
|
7
|
-
|
|
14
|
|
-
|
Share-based
payments
|
15
|
(427)
|
|
(938)
|
|
(537)
|
Total
operating costs
|
|
(3,187)
|
|
(4,899)
|
|
(2,975)
|
|
|
|
|
|
|
|
Operating
profit
|
|
7,005
|
|
19,568
|
|
7,071
|
|
|
|
|
|
|
|
Net foreign
currency movement
|
|
(163)
|
|
(22)
|
|
55
|
Finance
costs
|
3
|
(4,689)
|
|
(7,255)
|
|
(3,326)
|
|
|
|
|
|
|
|
Profit for
the period before tax
|
|
2,153
|
|
12,291
|
|
3,800
|
|
|
|
|
|
|
|
Taxation
expense
|
4
|
(181)
|
|
(683)
|
|
(408)
|
|
|
|
|
|
|
|
Total
comprehensive income for the period
|
|
1,972
|
|
11,608
|
|
3,392
|
|
|
|
|
|
|
|
Basic
earnings per share (pence)
|
5
|
0.47
|
|
2.81
|
|
0.83
|
Diluted
earnings per share (pence)
|
5
|
0.47
|
|
2.81
|
|
0.83
|
All income is attributable to the
holders of the Ordinary Shares of the Company.
CONDENSED
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
Note
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
|
£000
|
|
£000
|
|
£000
|
Non-current
assets
|
|
|
|
|
|
|
Goodwill
|
13
|
203
|
|
203
|
|
203
|
Hybrid
credit finance investments
|
6
|
185,871
|
|
177,589
|
|
174,149
|
Term credit
investments
|
7
|
5,382
|
|
5,382
|
|
4,652
|
Equity
investments
|
8
|
16,873
|
|
15,904
|
|
11,564
|
Trade and
other receivables
|
|
1,574
|
|
1,574
|
|
-
|
Deferred
tax
|
18
|
804
|
|
408
|
|
200
|
|
|
211,378
|
|
201,060
|
|
190,768
|
Current
assets
|
|
|
|
|
|
|
Hybrid
credit finance investments
|
6
|
32,195
|
|
33,359
|
|
26,521
|
Trade and
other receivables
|
10
|
31
|
|
843
|
|
1,529
|
Cash and
cash equivalents
|
|
9,181
|
|
2,896
|
|
5,971
|
Current tax
asset
|
|
186
|
|
155
|
|
463
|
|
|
41,593
|
|
37,253
|
|
34,484
|
|
|
|
|
|
|
|
Total
Assets
|
|
252,300
|
|
238,313
|
|
225,252
|
|
|
|
|
|
|
|
Current
liabilities
|
|
|
|
|
|
|
Hybrid
credit debt liabilities
|
9
|
160
|
|
170
|
|
167
|
Trade and
other payables
|
11
|
416
|
|
461
|
|
454
|
Borrowings
|
12
|
736
|
|
632
|
|
527
|
|
|
1,312
|
|
1,263
|
|
1,148
|
Non-current
liabilities
|
|
|
|
|
|
|
Hybrid
credit debt liabilities
|
9
|
944
|
|
934
|
|
988
|
Trade and
other payables
|
11
|
992
|
|
1,063
|
|
1,286
|
Borrowings
|
12
|
87,189
|
|
69,772
|
|
59,351
|
|
|
89,125
|
|
71,769
|
|
61,625
|
|
|
|
|
|
|
|
Net
Assets
|
|
161,863
|
|
165,281
|
|
162,479
|
|
|
|
|
|
|
|
Equity
|
|
|
|
|
|
|
Shares
issued
|
14
|
172,939
|
|
172,939
|
|
172,939
|
Share based
payment reserve
|
15
|
4,812
|
|
4,385
|
|
3,984
|
Warrant
reserve
|
15
|
3,036
|
|
3,036
|
|
3,036
|
Retained
losses
|
16
|
(18,924)
|
|
(15,079)
|
|
(17,480)
|
|
|
|
|
|
|
|
Total
Equity
|
|
161,863
|
|
165,281
|
|
162,479
|
NOTES TO THE
FINANCIAL STATEMENTS
1. General
Information
Duke Capital Limited ("Duke Capital" or the
"Company") is a company limited by shares, incorporated in Guernsey
under the Companies (Guernsey) Law, 2008. Its shares are traded on
the AIM market of the London Stock Exchange.
Throughout the period, the "Group" comprised
Duke Capital Limited and its wholly owned subsidiaries; Duke
Royalty UK Limited, Duke Capital US Holdings, Inc and Duke Capital
Employee Benefit Trust.
The Group's investing policy is to invest in a
diversified portfolio of hybrid credit finance and related
opportunities.
2. Significant
accounting policies
2.1 Basis
of preparation
The interim Condensed Consolidated
Financial Statements of the Group have been prepared in accordance
with UK adopted international accounting standards, and applicable
Guernsey law, and reflect the following policies, which have been
adopted and applied consistently.
On 31 December 2020, IFRS as adopted
by the European Union at that date was brought into the UK law and
became UK-adopted international accounting standards, with future
changes being subject to endorsement by the UK Endorsement Board.
The Group transitioned to UK-adopted international accounting
standards in its consolidated financial statements on 1 April 2021.
There was no impact or changes in accounting from the
transition.
These condensed consolidated interim financial
statements have been prepared in accordance with International
Accounting Standard ("IAS") 34 Interim Financial Reporting, as
adopted for use in the UK.
The accounting policies adopted in the
preparation of the interim Condensed Consolidated Financial
Statements are consistent with those followed in the preparation of
the Consolidated Financial Statements of the Group for the year
ended 31 March 2024.
No new or revised standards or interpretations
that have become effective during the period ended 30 September
2024 have had a material effect on the financial statements of the
Group.
The Directors consider that the Group has
adequate financial resources to enable it to continue operations
for a period of no less than 12 months from the date of approval of
the financial statements. Accordingly, the Directors believe that
it is appropriate to continue to adopt the going concern basis in
preparing the financial statements.
2.2 Going
concern
In assessing the going concern basis of
accounting the Directors have had regard to the guidance issued by
the Financial Reporting Council. After making enquiries and bearing
in mind the nature of the Company's business and assets, the
Directors consider that the Company has adequate resources to
continue in operational existence for the near future.
The cash flow needs of the Group have been
assessed taking account the need for further funding for any of the
existing hybrid credit partners and the ongoing working capital
needs of the business against the current cash and liquidity of the
Group.
2.3
Material accounting policies
In the application of the Group's accounting
policies, the Directors are required to make judgements, estimates
and assumptions about the carrying amounts of assets and
liabilities that are not readily apparent from other sources. The
estimates and associated assumptions are based on historical
experience and other factors that are relevant. Actual results may
differ from these estimates. The estimates and underlying
assumptions are reviewed on an ongoing basis. Revisions to
accounting estimates are recognised in the period in which the
estimate is revised if the revision affects only that period, or in
the period of the revision and future periods, if the revision
affects both current and future periods.
The principal accounting policies applied in the
presentation of the condensed consolidated interim financial
statements of Duke Capital, including the critical accounting
judgements made by the Directors and the key sources of estimation,
are consistent with those followed in the preparation of the
Group's Annual Report and consolidated financial statements for the
year ended 31 March 2024 and have been consistently applied
throughout the period ended 30 September 2024.
3. Finance
Costs
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Interest
payable on borrowings
|
4,268
|
|
6,413
|
|
2,905
|
Deferred
finance costs released to P&L
|
421
|
|
842
|
|
421
|
|
4,689
|
|
7,255
|
|
3,326
|
4. Income
tax
The Company has been granted exemption from
Guernsey taxation. The Company's subsidiary in the UK is subject to
taxation in accordance with relevant tax legislation.
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
Current tax
|
|
|
|
|
|
Income tax
expense
|
577
|
|
891
|
|
408
|
|
|
|
|
|
|
Deferred
tax
|
|
|
|
|
|
Decrease in
deferred tax assets
|
(396)
|
|
(208)
|
|
-
|
|
(396)
|
|
(208)
|
|
-
|
|
|
|
|
|
|
Income tax
expense
|
181
|
|
683
|
|
408
|
Factors
affecting income tax expense for the period
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Profit on
ordinary activities before tax
|
1,972
|
|
12,291
|
|
3,800
|
|
|
|
|
|
|
Guernsey
taxation at 0% (30 September 2023: 0%, 31 March 2024:
0%)
|
-
|
|
-
|
|
-
|
Overseas
tax charges at effective rate of 8.40% (30 September 2023: 10.73%,
31 March 2024: 5.55%)
|
181
|
|
683
|
|
408
|
Income tax
expense
|
181
|
|
683
|
|
408
|
5. Earnings per
share
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Total
comprehensive income (£000)
|
1,972
|
|
11,608
|
|
3,392
|
Weighted
average number of Ordinary Shares in issue, excluding treasury
shares (000s)
|
415,865
|
|
412,955
|
|
410,484
|
Basic
earnings per share (pence)
|
0.47
|
|
2.81
|
|
0.83
|
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Total
comprehensive income (£000)
|
1,972
|
|
11,608
|
|
3,392
|
Diluted
weighted average number of Ordinary Shares in issue, excluding
treasury shares (000s)
|
415,865
|
|
412,955
|
|
410,484
|
Diluted
earnings per share (pence)
|
0.47
|
|
2.81
|
|
0.83
|
Basic earnings per share is calculated by
dividing total comprehensive income for the period by the weighted
average number of shares in issue throughout the period, excluding
treasury shares (see Note 14). Diluted earnings per share
represents the basic earnings per share adjusted for the effect of
dilutive potential shares issuable on exercise of share options
under the Company's share-based payment schemes, weighted for the
relevant period.
All share options, warrants and Long-Term
Incentive Plan awards in issue are not dilutive at the year-end as
the exercise prices were above the average share price for the
period. However, these could become dilutive in future
periods.
Adjusted
earnings per share
Adjusted earnings represent the Group's
underlying performance from core activities. Adjusted earnings is
the total comprehensive income adjusted for unrealised and non-core
fair value movements, non-cash items and transaction-related costs,
including due diligence fees, together with the tax effects
thereon. Given the sensitivity of the inputs used to determine the
fair value of its investments, the Group believes that adjusted
earnings are a better reflection of its ongoing financial
performance.
Valuation and other non-cash movements such as
those outlined are not considered by management in assessing the
level of profit and cash generation of the Group. Additionally,
IFRS 9 requires transaction-related costs to be expensed
immediately whilst the income benefit is over the life of the
asset. As such, an adjusted earnings measure is used which reflects
the underlying contribution from the Group's core activities during
the year.
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Total
comprehensive income for the period
|
1,972
|
|
11,608
|
|
3,392
|
|
|
|
|
|
|
Unrealised
fair value movements
|
3,293
|
|
6,854
|
|
4,295
|
Expected
credit losses
|
-
|
|
(14)
|
|
-
|
Share-based
payments
|
427
|
|
938
|
|
537
|
Net
transaction costs
|
79
|
|
1,120
|
|
330
|
Tax effect
of the adjustments above at Group effective rate
|
(319)
|
|
(494)
|
|
(553)
|
Adjusted
earnings
|
5,452
|
|
20,012
|
|
8,001
|
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Adjusted
earnings for the year (£000)
|
5,452
|
|
20,012
|
|
8,001
|
Weighted
average number of Ordinary Shares in issue, excluding treasury
shares (000s)
|
415,865
|
|
412,955
|
|
410,484
|
Adjusted
earnings per share (pence)
|
1.31
|
|
4.85
|
|
1.95
|
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Diluted
adjusted earnings for the year (£000)
|
5,452
|
|
20,012
|
|
8,001
|
Diluted
weighted average number of Ordinary Shares in issue, excluding
treasury shares (000s)
|
415,865
|
|
412,955
|
|
410,484
|
Diluted
adjusted earnings per share (pence)
|
1.31
|
|
4.85
|
|
1.95
|
6. Hybrid credit
investments
Hybrid credit investments are financial assets
held at FVTPL that relate to the provision of hybrid credit capital
to a diversified portfolio of companies.
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Brought
forward
|
210,948
|
|
191,333
|
|
191,333
|
Additions
|
15,322
|
|
42,012
|
|
17,102
|
Buybacks
|
(3,987)
|
|
(17,636)
|
|
(7,041)
|
Loss on
hybrid credit assets at FVTPL
|
(4,217)
|
|
(4,761)
|
|
(724)
|
|
218,066
|
|
210,948
|
|
200,670
|
Hybrid credit investments are comprised
of:
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Non-current
|
185,871
|
|
177,589
|
|
174,149
|
Current
|
32,195
|
|
33,359
|
|
26,521
|
|
218,066
|
|
210,948
|
|
200,670
|
Hybrid credit investment income on the face of
the consolidated statement of comprehensive income
comprises:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Hybrid
credit interest
|
11,959
|
|
23,689
|
|
12,559
|
Hybrid
credit premiums
|
816
|
|
3,578
|
|
1,760
|
Total
hybrid credit cash revenue
|
12,775
|
|
27,267
|
|
14,319
|
Hybrid
credit equitised revenue
|
-
|
|
600
|
|
-
|
Loss on
hybrid credit assets at FVTPL
|
(4,217)
|
|
(4,761)
|
|
(724)
|
Loss on
hybrid credit liabilities at FVTPL
|
(46)
|
|
(92)
|
|
(81)
|
Hybrid
credit investment income
|
8,512
|
|
23,014
|
|
13,514
|
All financial assets held at FVTPL are
mandatorily measured as such.
The Group's hybrid credit investment assets
comprise hybrid credit financing agreements with 14
(30 September 2023: 15, 31 March 2024: 14) capital partners. Under
the terms of these agreements the Group advances funds in exchange
for annualised hybrid credit distributions. The
distributions are adjusted based on the change in the investees'
revenues, subject to a floor and a cap. The financing is secured by
way of fixed and floating charges over certain of the investees'
assets. The investees are provided with buyback options,
exercisable at certain stages of the agreements.
7. Term credit
investments
Term credit investments are financial assets
held at amortised cost except for the £2.2 million loan issued at
0% interest. The impact of discounting is immaterial to the
Consolidated Financial Statements. The below table shows both the
loans at amortised cost and fair value.
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Brought
forward
|
5,382
|
|
4,652
|
|
4,652
|
Additions
|
-
|
|
750
|
|
-
|
Buybacks
|
-
|
|
-
|
|
-
|
Expected
credit losses
|
-
|
|
(20)
|
|
-
|
|
5,382
|
|
5,382
|
|
4,652
|
The Group's loan investments comprise secured
loans advanced to two entities (30 September 2023: two, 31 March
2024: two) in connection with the Group's hybrid credit
investments.
The loans comprise fixed rate loans of
£5,382,000 (30 September 2023: £4,872,000, 31 March 2024:
£5,382,000) which bear interest at rates of between 0% and 5% (30
September 2023: 0% and 15%, 31 March 2024: 0% and 5%).
The loans mature as follows:
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
In less
than one year
|
-
|
|
-
|
|
-
|
In one to
two years
|
-
|
|
-
|
|
-
|
In two to
five years
|
5,382
|
|
5,382
|
|
4,652
|
|
5,382
|
|
5,382
|
|
4,652
|
Loan investment net income on the face of the
consolidated statement of comprehensive income
comprises:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Loan
interest
|
117
|
|
453
|
|
259
|
ECL
Analysis
The measurement of ECLs is primarily based on
the product of the instrument's probability of default ("PD"), loss
given default ("LGD"), and exposure at default ("EAD"). The Group
analyses a range of factors to determine the credit risk of each
investment. These include, but are not limited to:
·
liquidity and cash flows of the underlying
businesses
·
security strength
·
covenant cover
·
balance sheet strength
If there is a material change in these factors,
the weighting of either the PD, LGD or EAD increases, thereby
increasing the ECL impairment.
The disclosure below presents the gross and net
carrying value of the Group' loan investments by stage:
|
Gross carrying
amount
|
|
Allowance for
ECLs
|
|
Net
Carrying
amount
|
As at 30 September
2024
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Stage
1
|
5,402
|
|
(20)
|
|
5,382
|
Stage
2
|
-
|
|
-
|
|
-
|
Stage
3
|
-
|
|
-
|
|
-
|
|
5,402
|
|
(20)
|
|
5,382
|
|
Gross
carrying amount
|
|
Allowance
for ECLs
|
|
Net
Carrying
amount
|
As at 31
March 2024
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Stage
1
|
5,402
|
|
(20)
|
|
5,382
|
Stage
2
|
-
|
|
-
|
|
-
|
Stage
3
|
-
|
|
-
|
|
-
|
|
5,402
|
|
(20)
|
|
5,382
|
|
Gross
carrying amount
|
|
Allowance
for ECLs
|
|
Net
Carrying
amount
|
As at 30
September 2023
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Stage
1
|
4,692
|
|
(40)
|
|
4,652
|
Stage
2
|
-
|
|
-
|
|
-
|
Stage
3
|
-
|
|
-
|
|
-
|
|
4,692
|
|
(40)
|
|
4,652
|
Under the ECL model introduced by IFRS 9,
impairment provisions are driven by changes in credit risk of
instruments, with a provision for lifetime expected credit losses
recognised where the risk of default of an instrument has increased
significantly since initial recognition.
The credit risk profile of the investments has
not increased materially and they remain Stage 1 assets. No ECLs
have been charged in the period on these assets as they are not
deemed material.
The following table analyses Group's provision
for ECL's by stage for the period ended 30 September
2024:
|
Stage 1
|
|
Stage 2
|
|
Stage 3
|
|
Total
|
|
£000
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
|
|
At 1 April
2023 and 30 September 2023
|
92
|
|
-
|
|
-
|
|
92
|
Expected
credit losses on loan investments in period
|
20
|
|
-
|
|
-
|
|
20
|
Expected
credit losses on other receivables in year
|
(34)
|
|
|
|
|
|
(34)
|
Carrying
value at 31 March 2024 and 30 September 2024
|
78
|
|
-
|
|
-
|
|
78
|
8. Equity
investments
Equity investments are financial assets held at
FVTPL.
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Brought
forward
|
15,904
|
|
13,529
|
|
13,529
|
Additions -
cash
|
-
|
|
3,799
|
|
1,525
|
Additions -
equitised revenue
|
-
|
|
600
|
|
-
|
Disposals
|
-
|
|
(3)
|
|
-
|
Proceeds on
sale
|
-
|
|
(2,323)
|
|
-
|
Proceeds on
sale - deferred
|
-
|
|
(1,575)
|
|
-
|
Gain /
(loss) on equity assets at FVTPL
|
969
|
|
1,877
|
|
(3,490)
|
|
16,873
|
|
15,904
|
|
11,564
|
The Group's equity investments comprise
unlisted shares and warrants in 12 of its capital partners (30
September 2023: 12, 31 March 2024: 13).
The Group also still holds one (30 September
2023: two, 31 March 2024: two) unlisted investment in mining
entities from its previous investment objectives. The Board does
not consider there to be any future cash flows from the remaining
investments and they are fully written down to nil
value.
Equity investment net income on the face of the
consolidated statement of comprehensive income
comprises:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Unrealised
gain / (loss) on equity assets at FVTPL
|
969
|
|
325
|
|
(3,490)
|
Realised
gain on equity assets at FVTPL
|
21
|
|
1,552
|
|
-
|
Dividend
income
|
-
|
|
48
|
|
48
|
|
990
|
|
1,925
|
|
(3,442)
|
9. Hybrid credit debt
liabilities
Hybrid credit debt liabilities are financial
liabilities held at FVTPL.
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Brought
forward
|
1,104
|
|
1,142
|
|
1,142
|
Payments
made
|
(46)
|
|
(130)
|
|
(68)
|
Loss on
financial assets held at FVTPL
|
46
|
|
92
|
|
81
|
|
1,104
|
|
1,104
|
|
1,155
|
Hybrid credit debt liabilities are comprised
of:
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Current
|
160
|
|
170
|
|
167
|
Non-current
|
944
|
|
934
|
|
988
|
|
1,104
|
|
1,104
|
|
1,155
|
10. Trade and other
receivables
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
Current
|
|
|
|
|
|
Prepayments
and accrued income
|
31
|
|
101
|
|
25
|
Other
receivables
|
-
|
|
742
|
|
1,504
|
|
31
|
|
843
|
|
1,529
|
Non-current
|
|
|
|
|
|
Other
receivables
|
1,574
|
|
1,574
|
|
-
|
|
|
|
|
|
|
|
1,605
|
|
2,417
|
|
1,529
|
11. Trade and other
payables
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
Current
|
|
|
|
|
|
Trade
payables
|
67
|
|
13
|
|
20
|
Transaction
costs
|
238
|
|
342
|
|
316
|
Accruals
and deferred income
|
111
|
|
106
|
|
118
|
|
416
|
|
461
|
|
454
|
Non-current
|
|
|
|
|
|
Transaction
costs
|
992
|
|
1,063
|
|
1,286
|
|
|
|
|
|
|
|
1,408
|
|
1,524
|
|
1,740
|
12. Borrowings
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
Secured
loan
|
|
|
|
|
|
Current -
accrued interest
|
527
|
|
441
|
|
337
|
Non-current
|
59,351
|
|
53,930
|
|
34,363
|
|
59,878
|
|
54,371
|
|
34,700
|
At 30 September 2024,
£10,000,000 was undrawn on the facility (30 September
2023: £37,000,000, 31 March 2024:
£27,000,000).
At 30 September 2024, £964,000 of unamortised
fees were outstanding (30 September 2023: £1,247,000, 31 March
2024: £1,103,000).
The table below sets out an analysis of net debt
and the movements in net debt for the period ended 30 September
2024, the prior period and the year ended 31 March 2024.
|
Interest
Payable
|
|
Borrowings
|
|
£000
|
|
£000
|
|
|
|
|
At 1 April
2024
|
632
|
|
69,772
|
|
|
|
|
Cash
movements
|
|
|
|
Loan
advanced
|
-
|
|
17,000
|
Deferred
finance costs paid
|
-
|
|
(4)
|
Interest
paid
|
(4,162)
|
|
-
|
Non-cash
movements
|
|
|
|
Deferred
finance costs released to P&L
|
-
|
|
421
|
Interest
charged
|
4,268
|
|
-
|
As at 30
September 2024
|
736
|
|
87,189
|
|
Interest
Payable
|
|
Borrowings
|
|
£000
|
|
£000
|
|
|
|
|
At 1 April
2023
|
441
|
|
53,930
|
|
|
|
|
Cash
movements
|
|
|
|
Loan
advanced
|
-
|
|
5,000
|
Interest
paid
|
(2,819)
|
|
-
|
Non-cash
movements
|
|
|
|
Deferred
finance costs released to P&L
|
-
|
|
421
|
Interest
charged
|
2,905
|
|
-
|
As at 30
September 2023
|
527
|
|
59,351
|
Cash
movements
|
|
|
|
Loan
advanced
|
-
|
|
10,000
|
Interest
paid
|
(3,403)
|
|
-
|
Non-cash
movements
|
|
|
|
Deferred
finance costs released to P&L
|
-
|
|
421
|
Interest
charged
|
3,508
|
|
-
|
At 31 March
2024
|
632
|
|
69,772
|
13. Goodwill
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Goodwill
arising on business combination
|
203
|
|
203
|
|
203
|
14. Share capital
|
External
Shares
No.
|
|
Treasury
Shares
No.
|
|
Total
shares
No.
|
|
£000
|
Allotted, called up and fully
paid
|
|
|
|
|
|
|
|
At 1 April
2023
|
407,762
|
|
9,773
|
|
417,535
|
|
172,939
|
Shares
issued to Employee Benefit Trust during the period
|
-
|
|
3,955
|
|
3,955
|
|
-
|
PSA shares
vested during the period
|
7,665
|
|
(7,665)
|
|
-
|
|
-
|
At 30
September 2023 and 31 March 2024
|
415,427
|
|
6,063
|
|
421,490
|
|
172,939
|
|
|
|
|
|
|
|
|
Shares
issued to Employee Benefit Trust during the period
|
-
|
|
2,871
|
|
2,871
|
|
-
|
PSA shares
vested during the period
|
1,316
|
|
(1,316)
|
|
-
|
|
-
|
At 31 September
2024
|
416,743
|
|
7,618
|
|
424,361
|
|
172,939
|
There is a single class of shares. There are no
restrictions on the distribution of dividends and the repayment of
capital with respect to externally held shares. The shares held by
the Duke Capital Employee Benefit Trust are treated as treasury
shares. The rights to dividends and voting rights have been waived
in respect of these shares.
15. Equity-settled share-based
payments
Warrant
reserve
There were no movements in the warrant reserve
during the period:
|
Warrants
|
|
No. (000)
|
|
£000
|
|
|
|
|
At 1 April
2023
|
43,990
|
|
3,036
|
Lapsed
during the period
|
(2,375)
|
|
-
|
At 30
September 2023, 31 March 2024 and 30 September 2024
|
41,615
|
|
3,036
|
The warrants expire in January 2028 and have an
exercise price of 45 pence. As per IFRS 2, the warrants have been
valued using the Black Scholes model. A total expense of £2,771,000
has been capitalised and will be amortised over the life of the
warrants. In the period to 30 September 2024, an expense of
£277,000 (30 September 2023: £277,000, 31 March 2024: £554,000) was
recognised through finance costs in relation to the
warrants.
At 30 September 2024, 41,615,000 (30 September
2023: 41,615,000, 31 March 2024: 41,615,000) warrants were
outstanding and exercisable at a weighted average exercise price of
45 pence (30 September 2023: 46 pence, 31 March 2024: 45 pence).
The weighted average remaining contractual life of the warrants
outstanding was 3.26 years (30 September 2023: 4.26 years, 31 March
2024: 3.45 years).
Share-based
payment reserve
The following table shows the movements in the
share-based payment reserve during the period:
|
Share
options
|
|
LTIP
|
|
Total
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
At 1 April
2023
|
136
|
|
3,311
|
|
3,447
|
LTIP
awards
|
-
|
|
537
|
|
537
|
At 30
September 2023
|
136
|
|
3,848
|
|
3,984
|
|
|
|
|
|
|
LTIP
awards
|
-
|
|
401
|
|
401
|
At 31 March
2024
|
136
|
|
4,249
|
|
4,385
|
|
|
|
|
|
|
LTIP
awards
|
-
|
|
427
|
|
427
|
At 30
September 2024
|
136
|
|
4,676
|
|
4,812
|
Share option
scheme
The Group operates a share option scheme ("the
Scheme"). The Scheme was established to incentivise Directors,
staff and key advisers and consultants to deliver long-term value
creation for shareholders.
Under the Scheme, the Board of the Company will
award, at its sole discretion, options to subscribe for Ordinary
Shares of the Company on terms and at exercise prices and with
vesting and exercise periods to be determined at the time. However,
the Board of the Company has agreed not to grant options such that
the total number of unexercised options represents more than four
per cent of the Company's Ordinary Shares in issue from time to
time. Options vest immediately and lapse five years from the date
of grant.
No share options were granted during the period
to 30 September 2024 and there were nil options outstanding and
exercisable at 30 September 2024 (30 September 2023: 200,000, 31
March 2024: nil).
Long Term
Incentive Plan
Under the rules of the Long-Term Incentive Plan
("LTIP") the Remuneration Committee may grant Performance Share
Awards ("PSAs") which vest after a period of three years and are
subject to various performance conditions. The LTIP awards will be
subject to a performance condition based 50 per cent on total
shareholder return ("TSR") and 50 per cent on total cash available
for distribution ("TCAD per share"). TSR can be defined as the
returns generated by shareholders based on the combined value of
the dividends paid out by the Company and the share price
performance over the period in question. Upon vesting the awards
are issued fully paid.
The fair value of the LTIP awards consists of
(a) the fair value of the TSR portion; and (b) the fair value of
the TCAD per share portion. Since no consideration is paid for the
awards, the fair value of the awards is based on the share price at
the date of grant, as adjusted for the probability of the likely
vesting of the performance conditions. Since the performance
condition in respect of the TSR portion is a market condition, the
probability of vesting is not revisited following the date of
grant. The probability of vesting of the TCAD per share portion,
containing a non-market condition, is reassessed at each reporting
date. The resulting fair values are recorded on a straight-line
basis over the vesting period of the awards.
6,226,000 performance share awards (PSAs) were
granted during the period to 30 September 2024 (30 September 2023:
3,663,000, 31 March 2024: 3,663,000).
At 30 September 2024, 13,684,000 (30 September
2023: 9,726,000, 31 March 2024: 9,726,000) PSAs were outstanding.
The weighted average remaining vesting period of these awards
outstanding was 2.38 years (30 September 2023: 1.49 years, 31 March
2024: 1.30 years).
16. Distributable
reserves
Under Guernsey law, the Company can pay
dividends provided it satisfies the solvency test prescribed by the
Companies (Guernsey) Law, 2008. The solvency test considers whether
the Company is able to pay its debts when they fall due, and
whether the value of the Company's assets is greater than its
liabilities. The Company satisfied the solvency test in respect of
the dividends declared in the period.
17. Dividends
The following interim dividends have been
recorded in the period to 30 September 2024, 31 March 2024 and 30
September 2023:
|
|
Dividend
per
|
|
Dividends
|
|
|
share
|
|
payable
|
Record date
|
Payment
date
|
pence/share
|
|
£000
|
|
|
|
|
|
31-Mar-23
|
12-Apr-23
|
0.70
|
|
2,854
|
23-Jun-23
|
12-Jul-23
|
0.70
|
|
2,855
|
Dividends
payable for the period ended 30 September 2023
|
|
5,709
|
|
|
|
|
|
|
|
Dividend
per
|
|
Dividends
|
|
|
share
|
|
Payable
|
Record date
|
Payment
date
|
pence/share
|
|
£000
|
|
|
|
|
|
29-Sep-23
|
12-Oct-23
|
0.70
|
|
2,908
|
29-Dec-23
|
12-Jan-24
|
0.70
|
|
2,908
|
Dividends
payable for the period ended 31 March 2024
|
|
5,816
|
|
|
|
|
|
2-Apr-24
|
12-Apr-24
|
0.70
|
|
2,908
|
28-Jun-24
|
12-Jul-24
|
0.70
|
|
2,909
|
Dividends payable for the
period ended 30 September 2024
|
|
5,817
|
On 27 September 2024, the Company approved a
further quarterly cash dividend of 0.70 pence per share, totalling
£2,923,000, which was paid on 12 October 2023.
18. Deferred tax
|
Total
|
|
£000s
|
|
|
1 April
2023 and 30 September 2023
|
200
|
Credited to
profit & loss
|
208
|
At 31 March
2024
|
408
|
|
|
Credited to
profit & loss
|
396
|
At 30 September
2024
|
804
|
A deferred tax asset has been recognised as it
is expected that future available taxable profits will be available
against which the Group can use against the tax losses.
19. Related parties
Directors' fees
The following fees
were payable to the Directors during the period:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Short term
remuneration
|
871
|
|
1,206
|
|
831
|
Share-based
payments
|
215
|
|
464
|
|
256
|
|
1,086
|
|
1,670
|
|
1,087
|
Other related
party transactions
The following amounts were paid to related
parties during the period in respect of support services
fees:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Abingdon
Capital Corporation
|
322
|
|
533
|
|
263
|
Arlington
Group Asset Management Limited
|
50
|
|
100
|
|
50
|
|
313
|
|
633
|
|
313
|
Support Service Agreements with Abingdon Capital
Corporation ("Abingdon"), a company of which Neil Johnson is a
director, and Arlington Group Asset Management Limited
("Arlington"), a company of which Charles Cannon Brookes is a
director, were signed on 16 June 2015. The services to be provided
by both Abingdon and Arlington include global deal origination,
vertical partner relationships, office rental and assisting the
Board with the selection, execution and monitoring of capital
partners and investment performance. Abingdon fees also include
fees relating to remuneration of staff residing in North
America.
Dividends
The following dividends were paid to related
parties:
|
Period to
|
|
Year
to
|
|
Period
to
|
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
Directors
1
|
259
|
|
354
|
|
196
|
Other
related parties
|
36
|
|
92
|
|
50
|
|
295
|
|
446
|
|
246
|
1 Includes
dividends paid to Abinvest Corporation, a wholly owned subsidiary
of Abingdon Capital Corporation, and to Arlington Group Asset
Management
20. Fair value
measurements
Fair
value hierarchy
IFRS 13 requires disclosure of fair value
measurements by level of the following fair value
hierarchy:
Level
1: Inputs are quoted
prices (unadjusted) in active markets for identical assets and
liabilities that the entity can readily observe.
Level
2: Inputs are inputs other than quoted prices
included within Level 1 that are observable for the asset, either
directly or indirectly.
Level
3: Inputs that are not based on observable
market date (unobservable inputs).
The Group has classified its financial
instruments into the three levels prescribed as follows:
|
30-Sep-24
|
|
31-Mar-24
|
|
30-Sep-23
|
|
(unaudited)
|
|
(audited)
|
|
(unaudited)
|
|
£000
|
|
£000
|
|
£000
|
Financial
assets
|
|
|
|
|
|
Financial
assets at FVTPL
|
|
|
|
|
|
- Hybrid
credit investments
|
218,066
|
|
210,948
|
|
200,670
|
- Equity
investments
|
16,873
|
|
15,904
|
|
11,564
|
|
234,939
|
|
226,852
|
|
212,234
|
|
|
|
|
|
|
Financial
liabilities
|
|
|
|
|
|
Financial
liabilities at FVTPL
|
|
|
|
|
|
- Hybrid
credit debt liabilities
|
1,104
|
|
1,104
|
|
1,155
|
The following table presents the changes in
level 3 items for the periods ended 30 September 2024, 31 March
2024 and 30 September 2023:
|
Financial
|
|
Financial
|
|
|
|
Assets
|
|
Liabilities
|
|
Total
|
|
£000
|
|
£000
|
|
£000
|
|
|
|
|
|
|
At 1 April
2023
|
204,862
|
|
(1,142)
|
|
203,720
|
Additions
|
18,628
|
|
-
|
|
18,628
|
Repayments
|
(7,041)
|
|
-
|
|
(7,041)
|
Hybrid
credit income received
|
11,959
|
|
-
|
|
11,959
|
Hybrid
credit participation liabilities paid
|
-
|
|
68
|
|
68
|
Net change
in FV
|
(16,174)
|
|
(80)
|
|
(16,254)
|
At 30 September
2023
|
212,234
|
|
(1,154)
|
|
211,080
|
Additions
|
27,782
|
|
-
|
|
27,782
|
Repayments
|
(14,491)
|
|
-
|
|
(14,491)
|
Hybrid
credit income received
|
(34,974)
|
|
-
|
|
(34,974)
|
Hybrid
credit participation liabilities paid
|
-
|
|
61
|
|
61
|
Net change
in FV
|
36,301
|
|
(11)
|
|
36,290
|
At 31 March
2024
|
226,852
|
|
(1,104)
|
|
225,748
|
Additions
|
15,322
|
|
-
|
|
15,322
|
Repayments
|
(3,987)
|
|
-
|
|
(3,987)
|
Hybrid
credit income received
|
11,959
|
|
-
|
|
11,959
|
Hybrid
credit participation liabilities paid
|
-
|
|
46
|
|
46
|
Net change
in FV
|
(15,206)
|
|
(46)
|
|
(15,252)
|
At 30 September
2024
|
234,940
|
|
(1,104)
|
|
233,836
|
Valuation techniques used to determine
fair values
The fair value of the Group's hybrid credit
financial instruments is determined using discounted cash flow
analysis and all the resulting fair value estimates are included in
level 3. The fair value of the equity instruments is determined
applying an EBITDA multiple to the underlying businesses forward
looking EBITDA. All resulting fair value estimates are included in
level 3.
Valuation processes
The main level 3 inputs used by the Group are
derived and evaluated as follows:
Annual
adjustment factors for hybrid credit investments and hybrid credit
participation liabilities
These factors are estimated based upon the
underlying past and projected performance of the hybrid credit
investee companies together with general market
conditions.
Discount rates
for financial assets and financial liabilities
These are initially estimated based upon the
projected internal rate of return of the hybrid credit investment
and subsequently adjusted to reflect changes in credit risk
determined by the Group's Investment Committee.
EBITDA
multiples
These multiples are based on comparable market
transactions.
Forward
looking EBITDA
These are estimated based on the projected
underlying performance of the hybrid credit investee companies
together.
Changes in level 3 fair values are analysed at
the end of each reporting period and reasons for the fair value
movements are documented.
Valuation inputs and relationships to
fair value
The following summary outlines the quantitative
information about the significant unobservable inputs used in level
3 fair value measurements:
Hybrid credit
investments
The unobservable inputs are the annual
adjustment factor and the discount rate. The range of annual
adjustment factors used is -6.0% to 6.0% (30 September 2023: -6.0%
to 6.0%, 31 March 2024: -6.0% to 6.0%) and the range of
risk-adjusted discount rates is 14.7% to 17.7% (30 September 2023:
14.7% to 17.4%, 31 March 2024: 14.7% to 17.7%)
Equity
investments
The unobservable inputs are the EBITDA multiples
and forward-looking EBITDA. The range of EBITDA multiples used is
4.2x to 8.0x (30 September 2023: 5.3x to 10.0x, 31 March 2024: 4.2x
to 8.0x).
Hybrid credit
participation instruments
The unobservable inputs are the annual
adjustment factor and the discount rate. The range of annual
adjustment factors used is -6.0% to 6.0% (30 September 2023: -6.0%
to 6.0%, 31 March 2024: -6.0% to 6.0%) and the range of
risk-adjusted discount rates is 16.3% to 17.3% (30 September 2023:
16.3% to 17.4%, 31 March 2024: 16.3% to 17.7%).
21. Events after the financial
reporting date
Dividends
On 12 October 2024, the Company paid a quarterly
dividend of 0.70 pence per share.
On 22 November 2024, the Group announced the
successful placement of 85,454,636 new shares at a price of 27.5p
per share, raising new capital of £23.5 million.